Investing With I Bd

investors yeah and they came public in 2016 so they haven't been around even for a while but they went on a pretty amazing run in 2017. One of their big their key drugs is in phase three already approved for hochtans lufoma and now we're starting to see um phase three trials for that for non-small cell lung cancer which is another serious indication 23 other indications in late stage evaluation right now. When you get a hit with something like that you develop with big companies and it starts catching on you unleash your marketing team to commercialize the heck out of drugs like that. That's kind of where we are with Beijing that's really really fascinatingso there are a few